Chemed/$CHE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Chemed
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Ticker
$CHE
Sector
Primary listing
NYSE
Industry
Health Care Providers and Services
Headquarters
Employees
15,695
ISIN
US16359R1032
Website
Chemed Metrics
BasicAdvanced
$6.7B
22.29
$20.53
0.59
$2.00
0.44%
Price and volume
Market cap
$6.7B
Beta
0.59
52-week high
$623.61
52-week low
$452.05
Average daily volume
169K
Dividend rate
$2.00
Financial strength
Current ratio
1.729
Quick ratio
1.582
Long term debt to equity
8.638
Total debt to equity
12.275
Dividend payout ratio (TTM)
9.19%
Interest coverage (TTM)
231.21%
Profitability
EBITDA (TTM)
453.659
Gross margin (TTM)
34.82%
Net profit margin (TTM)
12.40%
Operating margin (TTM)
15.64%
Effective tax rate (TTM)
24.82%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
14.28%
Return on equity (TTM)
26.11%
Valuation
Price to earnings (TTM)
22.286
Price to revenue (TTM)
2.738
Price to book
5.66
Price to tangible book (TTM)
15.69
Price to free cash flow (TTM)
21.634
Free cash flow yield (TTM)
4.62%
Free cash flow per share (TTM)
2,114.50%
Dividend yield (TTM)
0.44%
Forward dividend yield
0.44%
Growth
Revenue change (TTM)
8.52%
Earnings per share change (TTM)
10.48%
3-year revenue growth (CAGR)
5.12%
10-year revenue growth (CAGR)
5.37%
3-year earnings per share growth (CAGR)
6.34%
10-year earnings per share growth (CAGR)
13.35%
3-year dividend per share growth (CAGR)
10.19%
10-year dividend per share growth (CAGR)
8.25%
What the Analysts think about Chemed
Analyst ratings (Buy, Hold, Sell) for Chemed stock.
Bulls say / Bears say
Chemed Corporation reported a 7.4% increase in revenue for Q3 2024, reaching $606.2 million, indicating strong operational performance. (Defense World)
The company declared a 25% increase in its quarterly dividend to $0.50 per share in August 2024, reflecting confidence in its financial health and commitment to shareholder returns. (CSIMarket)
VITAS Healthcare, a subsidiary of Chemed, expanded its operations by acquiring Covenant Care's hospice services in Florida and Alabama for $85 million in March 2024, enhancing its market presence. (CSIMarket)
Roto-Rooter, Chemed's plumbing and drain cleaning segment, reported a 6.9% decrease in revenue to $214.8 million in Q3 2024, indicating challenges in this business line. (Defense World)
The company's revenue growth of 7.23% in Q3 2023 was slightly below the Healthcare Facilities sector average of 7.58%, suggesting potential competitive pressures. (CSIMarket)
An insider sale of 1,326 shares by Executive Vice President Lee Spencer S on March 3, 2025, might raise concerns about internal perspectives on the company's valuation. (Financial Modeling Prep)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
Chemed Financial Performance
Revenues and expenses
Chemed Earnings Performance
Company profitability
Chemed News
AllArticlesVideos
Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
Business Wire·3 weeks ago
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Business Wire·2 months ago
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Chemed stock?
Chemed (CHE) has a market cap of $6.7B as of July 18, 2025.
What is the P/E ratio for Chemed stock?
The price to earnings (P/E) ratio for Chemed (CHE) stock is 22.29 as of July 18, 2025.
Does Chemed stock pay dividends?
Yes, the Chemed (CHE) stock pays dividends to shareholders. As of July 18, 2025, the dividend rate is $2 and the yield is 0.44%. Chemed has a payout ratio of 9.19% on a trailing twelve-month basis.
When is the next Chemed dividend payment date?
The next Chemed (CHE) dividend payment date is unconfirmed.
What is the beta indicator for Chemed?
Chemed (CHE) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.